Zura Bio (ZURA) pipeline and stated timing
Name in SEC filings: Zura Bio Ltd
No current calendar date is shown here. Retained program statements and source dates appear below.
Programs and stated timing
○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.
No source-verified calendar row is retained.
How this date was described over time
Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of .
No additional verified wording history is retained.
“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.
Retained program pages
tibulizumab
MatchedTopline data expected from HS and SSc Phase 2 studies in Q4 2026 and H1 2027, respectively
Watch ZURA
Request another SEC timing statement
Suggest an SEC timing statement to add for ZURA. You can include the original filing link in your note. The founder reads each request by hand.
Or email ORION.
Reading these records
- First stated window
- The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
- Disclosure date
- The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
- 1H, 2H, 1Q–4Q
- First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
- SEC original
- The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
- Status
- One of seven labels set by founder review of the original filings. Definitions: Methodology.